The loss of microvessels within αAMRs or AM22-52-treated tumors suggests that AM stimulation of CLR/RAMP2/RAMP3-expressing tumor vasculature acts as a survival mechanism for proliferating tumor endothelium. Here, DCLK3 is linked to neoplasm.